Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C41H32O26 |
Molecular Weight | 940.6772 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC(=CC(O)=C1O)C(=O)OC[C@H]2O[C@@H](OC(=O)C3=CC(O)=C(O)C(O)=C3)[C@H](OC(=O)C4=CC(O)=C(O)C(O)=C4)[C@@H](OC(=O)C5=CC(O)=C(O)C(O)=C5)[C@@H]2OC(=O)C6=CC(O)=C(O)C(O)=C6
InChI
InChIKey=QJYNZEYHSMRWBK-NIKIMHBISA-N
InChI=1S/C41H32O26/c42-17-1-12(2-18(43)28(17)52)36(57)62-11-27-33(64-37(58)13-3-19(44)29(53)20(45)4-13)34(65-38(59)14-5-21(46)30(54)22(47)6-14)35(66-39(60)15-7-23(48)31(55)24(49)8-15)41(63-27)67-40(61)16-9-25(50)32(56)26(51)10-16/h1-10,27,33-35,41-56H,11H2/t27-,33-,34+,35-,41+/m1/s1
Molecular Formula | C41H32O26 |
Molecular Weight | 940.6772 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 5 / 5 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Inhibition of human immunodeficiency viral replication by tannins and related compounds. | 1992 May |
|
Respiratory syncytial virus infection induces matrix metalloproteinase-9 expression in epithelial cells. | 2002 |
|
1,2,3,4,6-Penta-O-galloyl-beta-D-glucose protects rat neuronal cells (Neuro 2A) from hydrogen peroxide-mediated cell death via the induction of heme oxygenase-1. | 2002 Aug 9 |
|
Penta-O-galloyl-beta-D-glucose inhibits the invasion of mouse melanoma by suppressing metalloproteinase-9 through down-regulation of activator protein-1. | 2002 Oct 25 |
|
Inhibitory effects of the root cortex of Paeonia suffruticosa on interleukin-8 and macrophage chemoattractant protein-1 secretions in U937 cells. | 2003 Jan |
|
Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 activity by 1,2,3,4,6-penta-O-galloyl-beta-D-glucose in murine macrophage cells. | 2003 Oct |
|
Antiviral compounds from traditional Chinese medicines Galla Chinese as inhibitors of HCV NS3 protease. | 2004 Dec 20 |
|
Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells. | 2004 Jul |
|
Novel lipid-peroxidation- and cyclooxygenase-inhibitory tannins from Picrorhiza kurroa seeds. | 2004 Mar |
|
Penta-O-galloyl-beta-D-glucose inhibits phorbol myristate acetate-induced interleukin-8 [correction of intereukin-8] gene expression in human monocytic U937 cells through its inactivation of nuclear factor-kappaB. | 2004 Mar |
|
1,2,3,4,6-Penta-O-galloyl-beta-D-glucose blocks endothelial cell growth and tube formation through inhibition of VEGF binding to VEGF receptor. | 2004 May 10 |
|
In vitro anti-HCV activities of Saxifraga melanocentra and its related polyphenolic compounds. | 2005 |
|
Green tea: Health benefits as cancer preventive for humans. | 2005 |
|
Chemical identification of the sources of commercial Fructus Chebulae. | 2005 Jul-Aug |
|
Phenolic constituents of galla Rhois with hepatoprotective effects on tacrine- and nitrofurantoin-induced cytotoxicity in Hep G2 cells. | 2005 Nov |
|
Protein binding and astringent taste of a polymeric procyanidin, 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose, castalagin, and grandinin. | 2006 Dec 13 |
|
1,2,3,4,6-penta-O-galloyl-beta-D-glucose up-regulates heme oxygenase-1 expression by stimulating Nrf2 nuclear translocation in an extracellular signal-regulated kinase-dependent manner in HepG2 cells. | 2006 Jan 14 |
|
In vitro antiviral activity of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose against hepatitis B virus. | 2006 Oct |
|
Elastin stabilization for treatment of abdominal aortic aneurysms. | 2007 Apr 3 |
|
The isolation of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose from Acer truncatum Bunge by high-speed counter-current chromatography. | 2007 May 1 |
|
Bioactivity-guided isolation of the active compounds from Rosa nutkana and quantitative analysis of ascorbic acid by HPLC. | 2007 Sep |
|
Antioxidative activity of geranium (Pelargonium inquinans Ait) and its active component, 1,2,3,4,6-penta-O-galloyl-beta-D-glucose. | 2008 Apr |
|
Elaeocarpus sylvestris modulates gamma-ray-induced immunosuppression in mice: implications in radioprotection. | 2008 Aug |
|
1,2,3,4,6-penta-O-galloyl-beta-D-glucose from Galla Rhois protects primary rat hepatocytes from necrosis and apoptosis. | 2008 Sep |
|
Novel biological properties of Oenothera paradoxa defatted seed extracts: effects on metallopeptidase activity. | 2008 Sep 10 |
|
Melanogenesis inhibition by gallotannins from Chinese galls in B16 mouse melanoma cells. | 2009 Aug |
|
Tyrosinase inhibitors isolated from the roots of Paeonia suffruticosa. | 2009 May-Jun |
|
1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells. | 2010 |
|
Penta-O-galloyl-beta-D-glucose induces G1 arrest and DNA replicative S-phase arrest independently of cyclin-dependent kinase inhibitor 1A, cyclin-dependent kinase inhibitor 1B and P53 in human breast cancer cells and is orally active against triple negative xenograft growth. | 2010 |
|
1,2,3,4,6-penta-O-galloyl-beta-D-glucose protects splenocytes against radiation-induced apoptosis in murine splenocytes. | 2010 |
|
Simple in vitro assays to identify amyloid-beta aggregation blockers for Alzheimer's disease therapy. | 2010 |
|
Antioxidant effects of secondary metabolites from Geranium psilostemon. | 2010 Jun |
|
Effect of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose on elastase and hyaluronidase activities and its type II collagen expression. | 2010 Mar-Apr |
|
Intestinal alpha-glucosidase inhibitory activity and toxicological evaluation of Nymphaea stellata flowers extract. | 2010 Sep 15 |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 09:04:51 GMT 2023
by
admin
on
Sat Dec 16 09:04:51 GMT 2023
|
Record UNII |
3UI3K8W93I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3UI3K8W93I
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
PRIMARY | |||
|
131647-34-2
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
SUPERSEDED | |||
|
18082
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
PRIMARY | |||
|
102694-50-8
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
SUPERSEDED | |||
|
DTXSID901029765
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
PRIMARY | |||
|
99935-72-5
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
SUPERSEDED | |||
|
14937-32-7
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
PRIMARY | |||
|
1,2,3,4,6-Pentagalloyl glucose
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
PRIMARY | |||
|
98731-29-4
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
SUPERSEDED | |||
|
94008-28-3
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
SUPERSEDED | |||
|
65238
Created by
admin on Sat Dec 16 09:04:51 GMT 2023 , Edited by admin on Sat Dec 16 09:04:51 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> CONSTITUENT ALWAYS PRESENT | |||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
PGG decreased the level of extracellular HBV (IC50, 1.0m g/ml) in a dose-dependent manner. PGG also reduced the HBsAg level by 25% at a concentration of 4m g/ml.
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
MIC 160 mg/L of ATCC 700392 and ATCC 700824 strains of H. pylori
|
||
|
PARENT -> CONSTITUENT ALWAYS PRESENT |
The inhibition of protein tyrosine phosphatase 1B (PTP1B) is of substantial interest for the treatment of type-2 diabetes mellitus. Using an in vitro enzyme assay with human recombinant PTP1B 1,2,3,4,6-penta-O-galloyl-D-glucopyranose(1) was isolated from the roots of Paeonia lactiflora as an inhibitor of PTP1B, with an IC50 value of 4.8 uM.
|